论文部分内容阅读
目的通过针对脑梗死急性期住院患者所采取的不同药物治疗措施的成本-效果数据调查,分析药物成本与效果的关系以及可能呈现的规律性,尝试提供药品评价及改进治疗方案的新思路。方法通过采集样本信息并进行分类(组)整理,分析评价不同类别药物在不排除其它因素干扰的情况下体现的成本—效果关系。结果不同牛津郡社区卒中研究分型(OCSP)脑梗死患者在成本相近的情况下治疗效果有差异;二级预防以及在其基础上采取的不同辅助药物治疗措施均显示出治疗学意义,对于指导脑梗死急性期患者的药物治疗有帮助。结论对于脑梗死急性期患者,按照《中国急性缺血性脑卒中诊治指南》等采取相应的药物治疗,效果肯定;随着药物成本增加,治疗会产生一定的效果,然而继续增加成本,治疗效果提高有限;针对急性脑梗死患者治疗的不同类别药物成本-效果存在差异。
OBJECTIVE: To investigate the relationship between cost and effect of drugs and the regularity that may be presented through the cost-effectiveness data survey of different drug treatment measures taken in hospitalized patients with acute cerebral infarction and try to provide new ideas for drug evaluation and improvement of treatment options. Methods Through the collection of sample information and classification (group) sorting, analysis and evaluation of different types of drugs without excluding other factors interfere with the cost-effectiveness relationship. The results of different Oxfordshire community stroke classification (OCSP) patients with cerebral infarction at similar costs in the treatment of patients with different effects; secondary prevention and treatment on the basis of the different adjuvant therapy showed a therapeutic significance for the guidance Medication in patients with acute cerebral infarction is helpful. Conclusions For the patients with acute cerebral infarction, the corresponding drug treatment should be taken according to “Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke in China” and so on. The effect will be certain as the cost of medicine increases, however, the cost will be increased and the treatment effect will continue Increase limited; different types of drugs for the treatment of patients with acute cerebral infarction cost-effect differences.